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Abstract
Breast cancer in its advanced form constitutes a malignant neoplasm often causing metastases to distant
organs — especially bones, lungs and brain. Diagnostic studies rarely refer to untypical locations, which
— especially after a radical treatment of the basic illness — may lead to erroneous diagnoses, which in turn
may expose the patient to an ineffective and dangerous treatment. This study presents a case of a patient
radically treated due to the left breast cancer who after the period of two years exhibited symptoms of
increasing dysphagia. At first a gastric lymphoma was diagnosed, deriving from the lymphocytes B, or an
anaplastic gastric cancer. A bad general condition of the patient did not allow to introduce chemotherapy,
the patient was subject to a photodynamic endoscopic therapy six times, obtaining a complete symptom
relief liquidation and an improvement of the general condition. The progress of the neoplastic disease
observed during the symptom treatment in the palliative care consulting centre and hospitalization allowed
to diagnose a gastric metastasis of the breast cancer.
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Introduction
In spite of noticeable progress in the field of diag-
nosing and treating breast cancer with the use of
neoadjuvant radio- and chemotherapy, new surgical
techniques and neoadjuvant radiotherapy, it still
wreaks havoc with the population of middle-aged
women, and their age has a tendency to decrease. It
is also a neoplasm often causing metastases to dis-
tant organs — especially bones, lungs and brain. How-
ever, there also happen untypical locations which may
lead to erroneous diagnoses, and consequently to
inappropriate treatment. This study presents a case
of a patient radically treated due to the left breast
cancer who after the period of two years exhibited
symptoms of increasing dysphagia. On the basis of
an endoscopic examination and the histopathologic
examination result, the preliminary diagnosis suggest-
ed a gastric lymphoma deriving from the lympho-
cytes B or a neoplasm of an anaplastic cancer type.
However, due to the patient's bad general condi-
tion chemotherapy was not recommended, but ad-
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vanced dysphagia required the application of a pal-
liative procedure. During one year six events of an
endoscopic photodynamic therapy were performed,
each time obtaining the dysphagia liquidation and
a temporary improvement of the general condition,
manifesting in gaining weight. During the last but
one procedure, on the basis of the previous course
of the disease, metastases in the liver, bones, a final
diagnosis was formulated — a gastric metastasis of
the breast cancer.
Case study
A patient, aged 52, was admitted to the Palliative
Care Consulting Centre in January 2006 due to in-
creasing dysphagia resulting in the impossibility to
swallow solid and semi-liquid food and periodically
appearing vomiting after semi-liquid food. Two years
before the patient had been subject to a radical treat-
ment of the left breast cancer, which comprised the
neoadjuvant chemotherapy, and subsequently mas-
tectomy and radiotherapy.  Due to the fact that me-
tastasis foci in the subcutaneous tissue of the head,
groin and the left lower limb had been discovered
then, these changes had been removed in full. Due to
the symptoms intensification in the upper section of
the alimentary tract and a focal change described in
the CT of the abdominal cavity, arousing suspicions of
the neoplastic metastasis, the patient was directed to
the Clinic of Internal Diseases, Angiology and Physical
Medicine in Bytom in order to be subject to further
endoscopic diagnostics. In February 2006 the patient
was hospitalized for the first time. The endoscopic
examination performed then allowed to diagnose a
proliferative gastric disease; however the result of the
histopathologic test was ambiguous. At first the diag-
nosis described a neoplasm deriving from neuroendo-
crine cells, and subsequently, after the immunohisto-
chemical verification, the diagnosis was changed, sug-
gesting lymphoma deriving from the lymphocytes B or
an anaplastic cancer. Due to the general condition of
the patient and the results of oncologic consultations
qualifying the patient only to symptomatic proceed-
ings, the photodynamic therapy was commenced. In
February 2006 the first session was performed, lead-
ing to the elimination of dysphagia and improvement
of the patient’s general condition. The next sessions
took place in April, June, August 2006 and in August
and October 2007. Between the hospitalization peri-
ods the patient was under the care of the Palliative
Care Consulting Centre.
The symptoms from the upper section of the
alimentary tract were efficiently controlled, which
— together with the endoscopic treatment — sig-
nificantly improved the patient’s quality of life. The
symptomatic treatment comprised the application
of prokinetic drugs (metoclopramide), influencing
the upper section of the alimentary tract, glucocor-
ticoids (dexamethasone), aiming at a decrease of
the seeming size of the tumour by the elimination
of the inflammation areola, and — finally — the
megestrol acetate hindering the consequences of
the anorexia-cachexia syndrome. In August 206,
during another hospitalization in the clinic, the pres-
ence of minor quantities of free fluid in the  perito-
neum cavity was confirmed and the patient's com-
plaints allowed to diagnose bone metastases. In
August 2007 the quantities of fluids in the peritone-
um cavity were significant; however, introducing
diuretic drugs to the pharmacotherapy allowed to
resign from the decompression puncture. During
the last session of the photodynamic therapy, due
to the dynamics of the disease course and its clinical
image — metastases to the liver, free fluid in the
peritoneum cavity, the presence of fluid in the right
pleura cavity, as well as bone pains, the previous
diagnosis was revised and the gastric metastasis of
the breast cancer was diagnosed.
Every single photodynamic session was success-
ful as dysphagia was completely eliminated, the body
weight significantly increased and the patient’s qual-
ity of life was improved.
The patient was subject to the total of six pho-
todynamic sessions with a good result. Then symp-
tomatic proceedings were conducted in the Pallia-
tive Care Consulting Centre, consisting in ameliora-
tion of bone pains relating to the bones of the skull
integument, ribs and lower limbs, pharmacothera-
py of the abdominal dropsy and the cancerous
cachexia syndrome, as well as the application of
prokinetic drugs. An average remission period of
dysphagia and vomiting was two months in case
of the first four sessions. Next, the patient did not
require photodynamic therapy for the period of 12
months, the next two sessions took place in one-
month-long intervals.
At present the patient is still under the care of
the consulting centre referred to above.
Discussion
Both the primary neoplasms and metastases lo-
cated in the upper section of the alimentary tract
may be a reason for the occurrence of increasing
ailments such as dysphagia, odynophagia or even
vomiting leading to the patient’s cachexia and de-
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hydration. It is extremely important as often a dra-
matic deterioration in the patient’s condition is not
caused by the progress of the neoplastic disease,
but  by an unfortunate location of the tumour,
causing food passage disorders. Restoring the pa-
tency of the alimentary tract may lead to a similarly
quick improvement in the patient’s condition, and
consequently to the improvement of the quality of
the patient’s life, and finally even to its prolonga-
tion. The stricture of the inside diameter of the
oesophagus or stomach may be caused by an ex-
ternal pressure by a neoplastic exudates or by en-
larged lymph nodes of the mediastinum [1]. Also
an inflammation of the mucous membrane in the
oesophagus or stomach deriving from a mycotic,
bacterial infection or of the radiation nature may
be significant in the symptoms development. Final-
ly, the inflammatory infiltration around the neo-
plastic tumour may be a reason for the fact that its
actual dimensions are a sum of the size of the
neoplasm mass and the inflammatory oedema
which surrounds it [2].
First of all the symptomatic treatment should be
based on the pharmacotherapy of dysphagia basing
on the available prokinetic drugs (metoclopramide)
and anti-inflammatory drugs (dexamethasone). It
must be remembered that in some cases metoclo-
pramide may cause a reflexive contraction of the
superior sphincter of the oesophagus, increasing the
dysphagia [2]. We cannot forget about treating the
infection with the use of antibacterial and antimy-
cotic drugs, or acting locally and reducing inflam-
mation (1% solution of the hydrogen peroxide, ben-
zydamine, anti-inflammatory herbal mixtures). Bear-
ing in mind frequent radiation damages of the na-
ture of the salivary glands dysfunction, it is neces-
sary to apply locally preparations replacing the nat-
ural saliva. Finally, it is also crucial to apply — when-
ever it is not contraindicated — the megestrol ace-
tate which counteracts the occurrence of the neo-
plastic cachexia, which is the reason for the anorex-
ia — cachexia syndrome.
We must not forget about apparently obvious
frequency, composition and form of meals. The diet
must be rich in protein and oligoresidual.
Meals should be liquidized, served often in small
portions.
Unfortunately, in cases where the ailments relat-
ing to the neoplastic disease are caused by the tu-
mour expansion to the internal diameter of the stom-
ach or oesophagus, causing clogging it up, and
— even more often — peristalsis disorders not re-
acting to pharmacotherapy, it becomes necessary
to introduce more invasive procedures. Until recent-
ly the only methods of restoring the passage in the
upper section of the alimentary tract have been gas-
trostomies and nutritive jejunostomies.
At first they were performed during surgical pro-
cedures in the conditions of an operating theatre,
now, thanks to the development of the endoscopic
technology, it is possible to perform a percutaneous
endoscopic gastrostomy (PEG). Unfortunately, in
some cases even this method is not possible to be
performed, which is connected with a critical stric-
ture of the alimentary tract internal diameter, not
allowing an instrument to pass.
Sensible alternatives are constituted by the tu-
mour evaporization with the use of the YAG laser,
prosthesing the oesophagus, or the photodynamic
therapy. Especially the last mentioned method seems
to be very promising, mainly due to the possibility
of its frequent repetitions and a smaller risk — than
in the laser ablation — of complications in a form of
bleeding or perforations, as well as in the cases
where it is impossible to introduce self-expansible
prostheses — in the area of the cardia or in the next
sections of the stomach.
The principle of the last mentioned method is
destroying neoplastic cells with laser light of a de-
termined wavelength after gathering protoporphy-
rin in their mitochondria, applied before, constitut-
ing a photosensitizing agent [3]. Usually the session
of the laser irradiation is carried out after several
days from applying the substance as it is faster gath-
ered in the tumour in bigger quantities than in case
of healthy tissues and it is rinsed out of it more
slowly [1]. The polarized light causes cell apoptosis,
which in the macroscopic scale leads to the decrease
of the tumour size [3].
In Lightale's study a high efficiency of the photo-
dynamic therapy was confirmed, especially with
reference to tumours located in the pericardial area,
exceeding the methods with the application of the
YAG laser with reference to the symptoms remission
period [4].
Litle et al. analysed the results of the photody-
namic therapy in case of 215 patients suffering from
the oesophageal carcinoma in terms of the dysph-
agia remission and its duration, treated in the peri-
od 1996–2002.
He confirmed the occurrence of the symptoms
remission in case of 85% of patients with an aver-
age period of 66 days free from dysphagia. The
main, although not very frequent, side effects of the
treatment included hypersensitivity of the skin to
the sunlight in case of 6% of the patients [5].
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Other researchers in their studies also confirm
the efficiency and safety of this method. Luketich's
two-year-long observation of a group of 77 patients
subject to the photodynamic therapy of the oesoph-
ageal carcinoma proved 4-week-long periods free
from dysphagia and an improvement in terms of
this symptom in case of 90.8% of patients. Also in
this group skin reactions of the nature of sunburns
were confirmed in case of 10% of the patients [6].
Moghissi et al. collected the results of the photody-
namic treatment of patients suffering from oesoph-
ageal carcinoma for the period of the last fourteen
years. He proved a 100% satisfaction of patients
with this treatment method, both in the early and
late stage of the disease, with the main side effect
in a form of light hypersensitivity  appearing in case
of 5% of patients [7].
An interesting dissertation by Spinelli et al, con-
cerned in turn the photodynamic therapy applied in
case of patient suffering from the neoplasms of the
upper and lower section of the alimentary tract. It
proved an improvement in case of 74% and 97%,
respectively, after the palliative treatment of these
diseases [8].
Some researchers emphasize the advantage of
the photodynamic therapy over the endoscopic ab-
lation of a tumour with the use of the YAG laser.
Weigel in his study proved a smaller risk of per-
foration in case of an endoscopic phototherapy than
in case of the laser termoablation [9].
An unquestionable disadvantage, often deter-
mining the palliative nature of this method, is reach-
ing only the superficial parts of the tumour by the
laser light, which renders it impossible to destroy
neoplastic cells located deeper. Therefore photody-
namic sessions must be repeated due to the tumour
regrowth and the recurrence of the occlusion.
The author’s own observation refers to a patient
with the symptoms of dysphagia and vomiting, suf-
fering from the breast cancer metastasis to the peri-
cardial area of the stomach. It has been in progress
since January 2006. Throughout the whole treatment
period the patient has been given megestrol, gluco-
corticoids, prokinetic drugs, and in case of the aggra-
vation of ailments — parenteral hydration and opioid
painkillers. It must be stated that repeated endo-
scopic photodynamic sessions together with a com-
plex palliative pharmacotherapy aiming at decreas-
ing the seeming dimensions of the tumour and the
improvement of the peristalsis of the upper section
of the alimentary tract significantly contributed to
the improvement of the quality of the patient’s life.
Considering the fact that in January 2006 the patient
reported to the Palliative Care Consulting Centre with
the symptoms of a practical occlusion of the upper
section of the alimentary tract and she is still (i.e. in
November 2007) alive, this treatment method must
be recognized as an optimal one. The periods free
from dysphagia and vomiting lasted 8 weeks in case
of the first four sessions and 4 weeks in case of the
remaining two. The yearly interval between the fourth
and the fifth session was probably connected with a
gradual decrease of the food intake relating to the
anorexia-cachexia syndrome, and — to the same ex-
tent — to the application of anti-inflammatory, pro-
kinetic and antianorectic drugs. The frequency and
form of meals was also very significant.
Using the photodynamic therapy is even more
significant when we consider the fact that the initial
tests of histopathologic specimen of the gastric tu-
mour rather suggested the presence of a lymphoma
deriving from the lymphocytes B or an anaplastic
carcinoma, and not a breast cancer metastasis. The
original bad condition of the patient and the ex-
haustion of the chemotherapeutical options prior to
the radical treatment of the breast cancer preserved
the patient from an exhausting palliative chemo-
therapy aiming at restoring the patency of the ali-
mentary tract. The further clinical course, the loca-
tion and nature of metastases, allowed to confirm
the nature of the gastric tumour as a dissemination
of the breast cancer to distant organs.
Conclusions
1. The application of a complex symptomatic phar-
macotherapy, comprising megestrol, glucocorti-
coids, opiod painkillers, periodical parenteral hy-
dration prior to the photodynamic therapy con-
tributed to a significant improvement of the qual-
ity of the patient’s life, expressed in two-month-
long periods free from the symptoms and the pro-
longation of the survival time, which is measured
as a period of 20 months from the first session.
2. Repeated photodynamic sessions on the tumour
located in the pericardial area of the stomach
caused the symptoms remission of the occlusion
in the upper section of the alimentary tract in
case of a patient suffering from symptoms con-
nected with the neoplastic dissemination of the
breast cancer to the stomach.
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